High Prevalence of Short-Chain Acyl-CoA Dehydrogenase Deficiency in the Netherlands, but No Association with Epilepsy of Unknown Origin in Childhood

Abstract

Short-chain acyl-CoA dehydrogenase deficiency (SCADD) is an autosomal recessive inborn error of metabolism, most frequently associated with developmental delay and/or epilepsy. Most SCADD patients carry common SCAD-encoding gene (ACADS) variants or these variants in combination with a rare ACADS mutation, in the Netherlands predominantly the c.1058C>T. Epilepsy in childhood often remains unexplained and patients with epilepsy related to SCADD may remain undiagnosed because studies for SCADD are often not performed. To test this hypothesis and to further estimate the extent of the Dutch SCADD population, we performed a study on blood spot samples in 131 paediatric patients with epilepsy and 909 anonymous newborns and investigated the presence of the 2 common ACADS variants and the rare c.1058C>T mutation. Overall, the 2 common ACADS variants and the rare c.1058C>T mutation were detected in either homozygous or compound heterozygous forms in 9.2% of the epilepsy and 7.5% of the reference group. A birth prevalence of SCADD with a mutation/variant genotype in the Netherlands as high as >1:1 000 was calculated. This is in contrast with the low number of patients diagnosed clinically and supports the hypothesis that SCADD is clinically irrelevant. Furthermore our study does not support an association between SCADD and epilepsy.

Key words

short-chain acyl-CoA dehydrogenase deficiency - epilepsy - clinical relevance

References

• 1 Baumann RJ, Marx MB, Leonidakis MG. Epilepsy in rural Kentucky: prevalence in a population of school age children.  Epilepsia. 1978;  19 75-80
• 2 Beilmann A, Napa A, Soot A. et al . Prevalence of childhood epilepsy in Estonia.  Epilepsia. 1999;  40 1011-1019
• 3 Cavazzuti GB. Epidemiology of different types of epilepsy in school age children of Modena, Italy.  Epilepsia. 1980;  21 57-62
• 4 Centraal Bureau voor de Statistiek . http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL&PA=37422ned&D1=0,4–5,7,9,11,13,17,26,35,40–41&D2=0,10,20,30,40,(l–4)-l&HD=090218–0953&HDR=G1&STB=T 2010; 
• 5 Corydon MJ, Vockley J, Rinaldo P. et al . Role of common gene variations in the molecular pathogenesis of short-chain acyl-CoA dehydrogenase deficiency.  Pediatr Res. 2001;  49 18-23
• 6 Cowan LD. The epidemiology of the epilepsies in children.  Ment Retard Dev Disabil Res Rev. 2002;  8 171-181
• 7 den Boer ME, Ijlst L, Wijburg FA. et al . Heterozygosity for the common LCHAD mutation (1528g>C) is not a major cause of HELLP syndrome and the prevalence of the mutation in the Dutch population is low.  Pediatr Res. 2000;  48 151-154
• 8 Eriksson KJ, Koivikko MJ. Prevalence, classification, and severity of epilepsy and epileptic syndromes in children.  Epilepsia. 1997;  38 1275-1282
• 9 Gregersen N, Andresen BS, Bross P. Prevalent mutations in fatty acid oxidation disorders: diagnostic considerations.  Eur J Pediatr. 2000;  159 (S 03) S213-S218
• 10 Gregersen N, Andresen BS, Pedersen CB. et al . Mitochondrial fatty acid oxidation defects – remaining challenges.  J Inherit Metab Dis. 2008;  31 643-657
• 11 Gregersen N, Winter VS, Corydon MJ. et al . Identification of four new mutations in the short-chain acyl-CoA dehydrogenase (SCAD) gene in two patients: one of the variant alleles, 511C–>T, is present at an unexpectedly high frequency in the general population, as was the case for 625G–>A, together conferring susceptibility to ethylmalonic aciduria.  Hum Mol Genet. 1998;  7 619-627
• 12 Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940–1980.  Epilepsia. 1991;  32 429-445
• 13 Jallon P, Latour P. Epidemiology of idiopathic generalized epilepsies.  Epilepsia. 2005;  46 (S 09) 10-14
• 14 Jethva R, Bennett MJ, Vockley J. Short-chain acyl-coenzyme A dehydrogenase deficiency.  Mol Genet Metab. 2008;  95 195-200
• 15 Koeberl DD, Young SP, Gregersen NS. et al . Rare disorders of metabolism with elevated butyryl- and isobutyryl-carnitine detected by tandem mass spectrometry newborn screening.  Pediatr Res. 2003;  54 219-223
• 16 Kristensen MJ, Kmoch S, Bross P. et al . Amino acid polymorphism (Gly209Ser) in the ACADS gene.  Hum Mol Genet. 1994;  3 1711
• 17 Maldegem BT, Waterham HR, Duran M. et al . The 625G>A SCAD gene variant is common but not associated with increased C4-carnitine in newborn blood spots.  J Inherit Metab Dis. 2005;  28 557-562
• 18 Nagan N, Kruckeberg KE, Tauscher AL. et al . The frequency of short-chain acyl-CoA dehydrogenase gene variants in the US population and correlation with the C(4)-acylcarnitine concentration in newborn blood spots.  Mol Genet Metab. 2003;  78 239-246
• 19 Naito E, Indo Y, Tanaka K. Identification of two variant short chain acyl-coenzyme A dehydrogenase alleles, each containing a different point mutation in a patient with short chain acyl-coenzyme A dehydrogenase deficiency.  J Clin Invest. 1990;  85 1575-1582
• 20 Pedersen CB, Kolvraa S, Kolvraa A. et al . The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level.  Hum Genet. 2008;  124 43-56
• 21 Seidel J, Streck S, Bellstedt K. et al . Recurrent vomiting and ethylmalonic aciduria associated with rare mutations of the short-chain acyl-CoA dehydrogenase gene.  J Inherit Metab Dis. 2003;  26 37-42
• 22 Tein I, Elpeleg O, Ben-Zeev B. et al . Short-chain acyl-CoA dehydrogenase gene mutation (c.319C>T) presents with clinical heterogeneity and is candidate founder mutation in individuals of Ashkenazi Jewish origin.  Mol Genet Metab. 2008;  93 179-189
• 23 van Maldegem BT, Duran M, Wanders RJ. et al . Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency.  JAMA. 2006;  296 943-952
• 24 Waisbren SE, Levy HL, Noble M. et al . Short-chain acyl-CoA dehydrogenase (SCAD) deficiency: an examination of the medical and neurodevelopmental characteristics of 14 cases identified through newborn screening or clinical symptoms.  Mol Genet Metab. 2008;  95 39-45
• 25 Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material.  Biotechniques. 1991;  10 506-513

Correspondence